RBN013209

• CAT Number: I043865
• CAS Number: 2597933-17-8
• Molecular Formula: C19H24N6O3
• Molecular Weight: 384.43
• Purity: ≥95%
• Synonyms: 2-imidazol-1-yl-N-[4-(2-methoxyethoxy)cyclohexyl]-5H-pyrrolo[3,2-d]pyrimidine-4-carboxamide
• InChI: InChI=1S/C19H24N6O3/c1-27-10-11-28-14-4-2-13(3-5-14)22-18(26)17-16-15(6-7-21-16)23-19(24-17)25-9-8-20-12-25/h6-9,12-14,21H,2-5,10-11H2,1H3,(H,22,26)
• InChIKey: VQRPLBOIYMUPNF-UHFFFAOYSA-N
• SMILES: COCCOC1CCC(CC1)NC(=O)C2=NC(=NC3=C2NC=C3)N4C=CN=C4

RBN013209（Cat No.:I043865）is a highly specific inhibitor designed to target retinol-binding protein 4 (RBP4), a critical modulator of glucose and lipid metabolism. By inhibiting RBP4, RBN013209 aims to improve insulin sensitivity, making it a promising candidate for research into metabolic disorders such as type 2 diabetes and obesity. Its mechanism of action disrupts the RBP4-retinol interaction, potentially leading to better control of blood sugar levels and lipid homeostasis. RBN013209 is a valuable tool in preclinical studies, supporting the development of innovative treatments for metabolic diseases.